145 related articles for article (PubMed ID: 16949389)
1. Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors.
Crandall CJ; Crawford SL; Gold EB
Am J Med; 2006 Sep; 119(9 Suppl 1):S52-60. PubMed ID: 16949389
[TBL] [Abstract][Full Text] [Related]
2. Cognitive functioning and sex steroid hormone gene polymorphisms in women at midlife.
Kravitz HM; Meyer PM; Seeman TE; Greendale GA; Sowers MR
Am J Med; 2006 Sep; 119(9 Suppl 1):S94-S102. PubMed ID: 16949394
[TBL] [Abstract][Full Text] [Related]
3. The association of genetic polymorphisms in sex hormone biosynthesis and action with insulin sensitivity and diabetes mellitus in women at midlife.
Lo JC; Zhao X; Scuteri A; Brockwell S; Sowers MR
Am J Med; 2006 Sep; 119(9 Suppl 1):S69-78. PubMed ID: 16949391
[TBL] [Abstract][Full Text] [Related]
4. Sex steroid hormone pathway genes and health-related measures in women of 4 races/ethnicities: the Study of Women's Health Across the Nation (SWAN).
Sowers MR; Wilson AL; Karvonen-Gutierrez CA; Kardia SR
Am J Med; 2006 Sep; 119(9 Suppl 1):S103-10. PubMed ID: 16949383
[TBL] [Abstract][Full Text] [Related]
5. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition.
Randolph JF; Sowers M; Bondarenko I; Gold EB; Greendale GA; Bromberger JT; Brockwell SE; Matthews KA
J Clin Endocrinol Metab; 2005 Nov; 90(11):6106-12. PubMed ID: 16144949
[TBL] [Abstract][Full Text] [Related]
6. Sex steroid hormone gene polymorphisms and depressive symptoms in women at midlife.
Kravitz HM; Janssen I; Lotrich FE; Kado DM; Bromberger JT
Am J Med; 2006 Sep; 119(9 Suppl 1):S87-93. PubMed ID: 16949393
[TBL] [Abstract][Full Text] [Related]
7. CYP1A1 and CYP1B1 polymorphisms and their association with estradiol and estrogen metabolites in women who are premenopausal and perimenopausal.
Sowers MR; Wilson AL; Kardia SR; Chu J; McConnell DS
Am J Med; 2006 Sep; 119(9 Suppl 1):S44-51. PubMed ID: 16949388
[TBL] [Abstract][Full Text] [Related]
8. Endogenous estradiol and its association with estrogen receptor gene polymorphisms.
Sowers MR; Jannausch ML; McConnell DS; Kardia SR; Randolph JF
Am J Med; 2006 Sep; 119(9 Suppl 1):S16-22. PubMed ID: 16949384
[TBL] [Abstract][Full Text] [Related]
9. Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women.
Crandall CJ; Sehl ME; Crawford SL; Gold EB; Habel LA; Butler LM; Sowers MR; Greendale GA; Sinsheimer JS
Breast Cancer Res; 2009; 11(4):R51. PubMed ID: 19630952
[TBL] [Abstract][Full Text] [Related]
10. Characterizing variation in sex steroid hormone pathway genes in women of 4 races/ethnicities: the Study of Women's Health Across the Nation (SWAN).
Kardia SR; Chu J; Sowers MR
Am J Med; 2006 Sep; 119(9 Suppl 1):S3-15. PubMed ID: 16949386
[TBL] [Abstract][Full Text] [Related]
11. Sex steroid hormone polymorphisms, high-density lipoprotein cholesterol, and apolipoprotein A-1 from the Study of Women's Health Across the Nation (SWAN).
Sowers MR; Symons JP; Jannausch ML; Chu J; Kardia SR
Am J Med; 2006 Sep; 119(9 Suppl 1):S61-8. PubMed ID: 16949390
[TBL] [Abstract][Full Text] [Related]
12. The association of bone mineral density with estrogen receptor gene polymorphisms.
Greendale GA; Chu J; Ferrell R; Randolph JF; Johnston JM; Sowers MR
Am J Med; 2006 Sep; 119(9 Suppl 1):S79-86. PubMed ID: 16949392
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the estrogen synthesis and metabolism pathways and symptoms during the menopausal transition: observations from the Seattle Midlife Women's Health Study.
Woods NF; Mitchell ES; Tao Y; Viernes HM; Stapleton PL; Farin FM
Menopause; 2006; 13(6):902-10. PubMed ID: 16977255
[TBL] [Abstract][Full Text] [Related]
14. Association of genetic variation in the tachykinin receptor 3 locus with hot flashes and night sweats in the Women's Health Initiative Study.
Crandall CJ; Manson JE; Hohensee C; Horvath S; Wactawski-Wende J; LeBlanc ES; Vitolins MZ; Nassir R; Sinsheimer JS
Menopause; 2017 Mar; 24(3):252-261. PubMed ID: 28231077
[TBL] [Abstract][Full Text] [Related]
15. Does everyday discrimination account for the increased risk of vasomotor symptoms in Black women?: the Study of Women's Health Across the Nation (SWAN).
Reeves AN; Lewis TT; Hood MM; Thurston RC; Avis NE; Burnett-Bowie SM; Cortés YI; Neal-Perry G; Harlow SD
Menopause; 2024 Jun; 31(6):484-493. PubMed ID: 38595299
[TBL] [Abstract][Full Text] [Related]
16. Association of menopausal vasomotor symptoms with increased bone turnover during the menopausal transition.
Crandall CJ; Tseng CH; Crawford SL; Thurston RC; Gold EB; Johnston JM; Greendale GA
J Bone Miner Res; 2011 Apr; 26(4):840-9. PubMed ID: 20878774
[TBL] [Abstract][Full Text] [Related]
17. Menstrual cycle markers of ovarian aging and sex steroid hormone genotypes.
Sowers MR; Jannausch ML; McConnell DS; Kardia SR; Randolph JF
Am J Med; 2006 Sep; 119(9 Suppl 1):S31-43. PubMed ID: 16949387
[TBL] [Abstract][Full Text] [Related]
18. The association of an alpha2C adrenoreceptor gene polymorphism with vasomotor symptoms in African American women.
Aharon DA; Friedman EG; Overbey JR; McLaughlin M; Langaee T; Thurston RC
Menopause; 2019 Mar; 26(3):300-305. PubMed ID: 30277919
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal analysis of changes in weight and waist circumference in relation to incident vasomotor symptoms: the Study of Women's Health Across the Nation (SWAN).
Gold EB; Crawford SL; Shelton JF; Tepper PG; Crandall CJ; Greendale GA; Matthews KA; Thurston RC; Avis NE
Menopause; 2017 Jan; 24(1):9-26. PubMed ID: 27749738
[TBL] [Abstract][Full Text] [Related]
20. Phytoestrogen and fiber intakes in relation to incident vasomotor symptoms: results from the Study of Women's Health Across the Nation.
Gold EB; Leung K; Crawford SL; Huang MH; Waetjen LE; Greendale GA
Menopause; 2013 Mar; 20(3):305-14. PubMed ID: 23435028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
